Home Search
eoe - search results
If you're not happy with the results, please do another search
How the First FDA-Approved Therapy for Peanut Allergy is Helping Families
What is PALFORZIA?
PALFORZIA is a treatment for people who are allergic to peanuts. PALFORZIA can help reduce the severity of allergic reactions, including anaphylaxis,...
Dupixent (dupilumab) Study Shows Significant Improvement in Eosinophilic Esophagitis Signs and Symptoms
Phase 3 trial in (EoE) to show a significantly improved structural and histologic measures, while rapidly improving ability to swallow in patients 12 years and older
The FASTER Act: What It Does and Why YOU Need to Help Pass It
FARE can't do it alone: Do your part to help pass the FASTER Act.
End Allergies Together, Responsible for Funding Important Research, is Winding Down Operations
"We are grateful to all of those who have supported us and helped E.A.T make such a significant impact on the food allergy industry."
Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101 in Children and...
“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
High-Tech Tissue Study Reveals Which Cells Drive a Painful Food Allergy
Findings from Cincinnati Children’s also raise questions about butyrate, a popular food supplement.
European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary Endpoint
Company Intends to Submit European MAA in Mid-2019.
Phase II Trials of AR101 with Dupilumab for Peanut Allergy to Begin
Study scheduled to commence next week.
ACAAI: Advice to Allergists Regarding Private Practice OIT
Although intended for allergists, a good read for families considering OIT as well.
Discovery Could Lead To Personalized Medical Therapies for Emerging New Food Allergy Disorder
"Our goal is to provide the type of deep disease understanding and therapeutic decision-making that is now becoming routine in the cancer field."









